Utah Medical Products Inc (UTMD)
66.29
-0.87
(-1.30%)
USD |
NASDAQ |
Apr 25, 16:00
66.37
+0.08
(+0.12%)
After-Hours: 20:00
Utah Medical Products Cash from Financing (TTM): -4.165M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -4.165M |
September 30, 2023 | -4.014M |
June 30, 2023 | -4.011M |
March 31, 2023 | -6.552M |
December 31, 2022 | -5.484M |
September 30, 2022 | -12.63M |
June 30, 2022 | -12.45M |
March 31, 2022 | -9.937M |
December 31, 2021 | -10.90M |
September 30, 2021 | -3.777M |
June 30, 2021 | -4.295M |
March 31, 2021 | -4.263M |
December 31, 2020 | -10.73M |
September 30, 2020 | -10.76M |
June 30, 2020 | -10.37M |
March 31, 2020 | -10.72M |
December 31, 2019 | -4.227M |
September 30, 2019 | -5.453M |
June 30, 2019 | -5.395M |
March 31, 2019 | -4.849M |
December 31, 2018 | -4.777M |
September 30, 2018 | -3.49M |
June 30, 2018 | -3.501M |
March 31, 2018 | -3.564M |
December 31, 2017 | -2.653M |
Date | Value |
---|---|
September 30, 2017 | -6.437M |
June 30, 2017 | -6.437M |
March 31, 2017 | -6.435M |
December 31, 2016 | -6.34M |
September 30, 2016 | -3.53M |
June 30, 2016 | -3.97M |
March 31, 2016 | -4.054M |
December 31, 2015 | -8.891M |
September 30, 2015 | -9.827M |
June 30, 2015 | -10.50M |
March 31, 2015 | -12.26M |
December 31, 2014 | -8.261M |
September 30, 2014 | -8.108M |
June 30, 2014 | -7.754M |
March 31, 2014 | -6.75M |
December 31, 2013 | -6.60M |
September 30, 2013 | -7.454M |
June 30, 2013 | -8.396M |
March 31, 2013 | -9.891M |
December 31, 2012 | -11.17M |
September 30, 2012 | -11.59M |
June 30, 2012 | -11.50M |
March 31, 2012 | -10.59M |
December 31, 2011 | 18.08M |
September 30, 2011 | 17.64M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-12.63M
Minimum
Sep 2022
-3.777M
Maximum
Sep 2021
-7.376M
Average
-5.484M
Median
Dec 2022
Cash from Financing (TTM) Benchmarks
Perspective Therapeutics Inc | 0.785M |
Retractable Technologies Inc | 0.9416M |
Xtant Medical Holdings Inc | 19.69M |
Asensus Surgical Inc | 9.626M |
Catheter Precision Inc | 8.386M |